GeneWeave Biosciences

GeneWEAVE, Inc. is a privately-held in vitro diagnostics company headquartered in Los Gatos, California. The company employs a team of four individuals and generates an annual revenue of $5 million. GeneWEAVE specializes in developing diagnostic solutions for clinical microbiology, focusing on combating drug-resistant bacteria. Their innovative Smarticles® technology enables healthcare providers to rapidly detect drug resistance and measure susceptibility information directly from patient samples. This "Sample-In/Susceptibility-Out" approach eliminates the need for traditional time-consuming methods like enrichment, culture, or sample preparation. The company's diagnostic solutions aim to support impactful surveillance programs, provide early therapy guidance, and promote effective antibiotic stewardship. GeneWEAVE's work contributes to improving patient outcomes and addressing the growing challenge of antimicrobial resistance. For more information about GeneWEAVE and its products, visit their website at geneweave.com.